Now out in @CR_AACR: We mine the epigenetic underpinnings of #AlveolarSoftPartSarcoma utilizing patient samples, preclinical models, and functional tags (dTAG, BioID) to define the oncogenic transcriptional program driven by ASPSCR1::TFE3 and actionable therapeutic liabilities:
Our lab is recruiting both a postdoc and research technician to start in May/June! If you know anyone interested in investigating mechanisms of metastasis and immune suppression in cancer through developing innovative mouse models and studying senescence, please spread the word!
Fred Hutch and the University of Washington are jointly recruiting a Director of Clinical Research for #Sarcoma — a physician-scientist ready to lead a collaborative sarcoma clinical research program across our institutions. Learn more and apply: bit.ly/4tf6kVr#hiring
Federal funding for US biomedical research is moribund.
Since October 1 2025, NIH is -80% in new grants and -70% in values (total dollars).
Labs are closing down and researchers are leaving science.
To what end?
SFA is accepting applications for the 2026 Last Mile Sarcoma Research Award. This one-year, $150,000 grant supports sarcoma researchers seeking to strengthen the resubmission of R01 or equivalent proposals focused on advancing the understanding and treatment of sarcoma. Applications are due by February 2, 2026, at 5:00 pm ET.
#sarcoma#curesarcoma#sarcomaresearch
The highlight of the Strategic Advances in Sarcoma Science (SASS) conference @NIH was the phenomenal work presented by @FavourFavvycool, @YiHsuanH83, and many others! Energizing advocacy for #Sarcoma research and terrific representation from @UMassChan@UMassCancerCtr.
The Department of Medicine would like to thank Dr. Matthew Hemming for presenting "Sarcoma: Rare Origins to Modern Insights — History, Clinical Care, Research and the Challenges Ahead" at today's Medical Grand Rounds!
Music created and provided by Dr. Karen Salomon-Escoto.
Dr. Matt Hemming @SarcomaLab presented his research on exploiting metabolic dysregulation in SDH-deficient GIST, offering valuable insights into new strategies that may advance treatment options for this rare subtype.
#CTOS2025#GIST#SDHGIST#SarcomaResearch
Next week, our 2026 Research Grant application is closing. Submit your Letter of Intent by November 6 to be considered.
SFA encourages applications in ALL areas of sarcoma research from both U.S. and international applicants. Researchers are invited to submit LOIs for proposals in pre-clinical, translational, and clinical research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas.
Learn more about eligibility, funding details, and the review and selection process on our website at buff.ly/Hw5uaPv
Brilliant science and autumn inspiration at the UMass Cancer Biology Retreat @UMassChan@UMassCancerCtr! Kudos to @FavourFavvycool for an invited talk and @YiHsuanH83 for the TOP POSTER award — #Sarcoma research shining even brighter than the New England fall leaves!
We are hiring @CUCancerCenter for #sarcoma faculty! Lots of patients, cutting edge clinical trials, a phenomenal multidisciplinary team, and all this with beautiful mountains to play in! DM me for details and feel free to share!
July is #SarcomaAwarenessMonth. This year, Michelle Cormier-Del Orbe, a #UMassMemorial patient diagnosed with stage 4 Malignant PEComa, made it her mission to illuminate the Burns Memorial Bridge in Shrewsbury/Worcester... and, she did it! #LightUpForSarcoma
📸: Joan Sanders
Read Pukkila-Worley, MD, is the new director of the MD/PhD program: direc.to/n8PN
Dr. Pukkila-Worley has mentored dozens of MD/PhD graduate students since joining @UMassChan in 2014. The @RPWLab studies host-pathogen interactions and bacterial pathogenesis. @UMassMDPhD
🗣️ We're hiring a Director of Preclinical Research! This is an exciting opportunity for an oncology R&D leader to make a tangible impact in the lives of patients in urgent need of new treatment options.
More info: chordoma.org/team/careers/
PhD candidate Favour Akabogu is working to develop new therapies for a rare type of sarcoma called gastrointestinal stromal tumor (GIST), a tumor that develops throughout the gastrointestinal tract: brnw.ch/21wTruo#StudentSpotlight#Research#PhD@SarcomaLab
ALT Members of the Hemming lab L-R back row: Wesley Marshall. Yi-Hsuan Hseih, Shahid Banday. L-R front row: Favour Akabogu, Matthew Hemming, MD, PhD.